Ocular implant and delivery system
An illustrative method for reducing intraocular pressure in a patient may comprise deploying an ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye and administering a therapeutic agent comprising a Rho kinase (ROCK) inhibitor to the patient. The ocular implant may be configured to lower the intraocular pressure from an initial to a second pressure within a first range and the therapeutic agent may lower an intraocular pressure to a third pressure within a second range, the third pressure lower than the second pressure.
1. A method for reducing intraocular pressure in a patient, the method comprising:
deploying an ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye, the ocular implant comprising:
a tubular body having an inner surface and an outer surface, the tubular body extending in a curved volume whose longitudinal axis forms an arc of a circle; and
a plurality of open areas and strut areas formed in the tubular body, the strut areas surrounding the plurality of open areas; and
a pressure sensor disposed on the inner surface of the tubular body, wherein deployment of the ocular implant is configured to lower an intraocular pressure of the eye from an initial pretreatment pressure to a second pressure; and
administering a therapeutic agent comprising a Rho kinase (ROCK) inhibitor to the patient after the deployment of the ocular implant to lower the intraocular pressure to a third pressure lower than the second pressure, wherein the therapeutic agent comprising the Rho kinase (ROCK) inhibitor is administered to the patient using an eye dropper or a syringe.
2. The method of claim 1 , wherein deploying the ocular implant comprises:
inserting a distal end of a cannula through an incision in the eye and into an anterior chamber of the eye;
placing a distal opening of the cannula into fluid communication with Schlemm's canal such that the cannula enters Schlemm's canal in a substantially tangential orientation;
advancing the ocular implant distally through the cannula with a delivery tool engaged with the ocular implant, a proximal portion of the ocular implant engaging the delivery tool proximal to a distal portion of the delivery tool; and
disengaging the ocular implant and the delivery tool when the proximal portion of the ocular implant reaches the distal opening of the cannula.
3. The method of claim 1 , wherein the pressure sensor is disposed within an elongate channel defined by the inner surface.
4. The method of claim 3 , wherein the pressure sensor is disposed adjacent to an opening defined along the ocular implant.
5. The method of claim 3 , wherein the pressure sensor is disposed within an opening defined along the ocular implant.
6. The method of claim 3 , wherein the pressure sensor comprises a first substrate disposed on a second substrate, wherein the second substrate is flexible to allow the second substrate to be mounted flush against the inner surface of the ocular implant.
7. The method of claim 1 , wherein the tubular body of the ocular implant comprises a plurality of spines and supporting frames, where at least one of the spines comprises a first major side, a second major side, a first minor side, and a second minor side, wherein the at least one of the spines comprises a thickness extending between the first major side and the second major side and a width extending between the first minor side and the second minor side, and wherein a ratio of the width to the thickness is greater than 2.
8. The method of claim 1 , further comprising obtaining a pressure reading from the pressure sensor using a device located outside of the body of the patient, wherein the pressure reading is an instantaneous pressure reading during deployment of the ocular implant or shortly thereafter.
9. A method for reducing intraocular pressure in a patient, the method comprising:
deploying an ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye, the ocular implant comprising:
a tubular body having an inner surface and an outer surface, the tubular body extending in a curved volume whose longitudinal axis forms an arc of a circle; and
a plurality of open areas and strut areas formed in the tubular body, the strut areas surrounding the plurality of open areas; and
a pressure sensor disposed on the inner surface of the tubular body, wherein deployment of the ocular implant is configured to lower an intraocular pressure of the eye from an initial pretreatment pressure to a second pressure; and
administering a therapeutic agent comprising a Rho kinase (ROCK) inhibitor to the patient before the deployment of the ocular implant, and wherein the therapeutic agent comprising the Rho kinase (ROCK) inhibitor is administered to the patient using an eye dropper or a syringe.
10. A method for reducing intraocular pressure in a patient, the method comprising;
inserting a distal end of a cannula through an incision in an eye and into an anterior chamber of the eye, wherein the cannula comprises a pressure sensor located within a trough at the distal end of the cannula;
placing a distal opening of the cannula into fluid communication with Schlemm's canal such that the cannula enters Schlemm's canal in a substantially tangential orientation;
deploying an ocular implant out of the cannula, wherein the ocular implant is adapted to reside at least partially in a portion of Schlemm's canal of the eye, the implant comprising:
a tubular body having an inner surface and an outer surface, the tubular body extending in a curved volume whose longitudinal axis forms an arc of a circle; and
a plurality of open areas and strut areas formed in the tubular body, the strut areas surrounding the plurality of open areas wherein deployment of the ocular implant is configured to lower an intraocular pressure of the eye from an initial pressure to a second pressure less than the initial pressure, wherein the implant further comprises an implant pressure sensor disposed on the inner surface of the tubular body such that the implant pressure sensor is within an elongate channel defined by the inner surface.
11. The method of claim 10 , wherein deploying the ocular implant further comprises:
advancing the ocular implant distally through the cannula with a delivery tool engaged with the ocular implant, a proximal portion of the ocular implant engaging the delivery tool proximal to a distal portion of the delivery tool; and
disengaging the ocular implant and the delivery tool when the proximal portion of the ocular implant reaches the distal opening of the cannula.
12. The method of claim 10 , further comprising administering a therapeutic agent comprising a Rho kinase (ROCK) inhibitor to the patient after the deployment of the ocular implant to lower the intraocular pressure to a third pressure lower than the second pressure, wherein the therapeutic agent comprising the Rho kinase (ROCK) inhibitor is administered to the patient using an eye dropper or a syringe.
13. The method of claim 10 , further comprising obtaining a pressure reading from the pressure sensor using a device located outside of the body of the patient, wherein the pressure reading is an instantaneous pressure reading during deployment of the ocular implant or shortly thereafter.
14. The method of claim 10 , further comprising administering a therapeutic agent comprising a Rho kinase (ROCK) inhibitor to the patient before the deployment of the ocular implant, and wherein the therapeutic agent comprising the Rho kinase (ROCK) inhibitor is administered to the patient using an eye dropper or a syringe.
15. The method of claim 10 , wherein the implant pressure sensor is disposed adjacent to an opening defined along the ocular implant.
16. The method of claim 10 , wherein the implant pressure sensor is disposed within an opening defined along the ocular implant.
17. The method of claim 10 , wherein the implant pressure sensor comprises a first substrate disposed on a second substrate, wherein the second substrate is flexible to allow the second substrate to be mounted flush against the inner surface of the ocular implant.
18. The method of claim 10 , wherein the tubular body of the ocular implant comprises a plurality of spines and supporting frames, where at least one of the spines comprises a first major side, a second major side, a first minor side, and a second minor side, wherein the at least one of the spines comprises a thickness extending between the first major side and the second major side and a width extending between the first minor side and the second minor side, and wherein a ratio of the width to the thickness is greater than 2.